Bruker Corporation
BRKR NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 4, 2026
ET
EPS Est.
0.38
EPS Actual
0.49
Revenue Est.
$853.6M
Revenue Actual
$838.5M
Next Earnings Report
Date
Nov 2, 2026 · Mon
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
0.42
Revenue Est.
$867.4M
Company Overview
Bruker Corporation (ticker BRKR) is listed on NASDAQ with a market cap of about $9.07B. Its next earnings report (FY2026 Q3) is expected on Nov 2, 2026 (ET), Pre-market, with consensus EPS of 0.42. In the last 15 reported quarters, EPS beat consensus estimates 11 times.
Actual EPS TrendRecently15Term · Feb 9, 2023 → Aug 4, 2026
Feb 9, 2023Range: 0.31 ~ 0.76Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | 0.38 | Above forecast↑0.49 | $853.6M | $838.5M |
| May 6, 2026 | -- | 0.23 | Above forecast↑0.31 | $795.6M | $823.4M |
| Feb 12, 2026 | -- | 0.65 | 0.59 | $962.3M | $977.2M |
| Nov 3, 2025 | -- | 0.33 | Above forecast↑0.60 | $964.6M | $860.5M |
| Aug 4, 2025 | -- | 0.33 | 0.32 | $810.2M | $797.4M |
| May 7, 2025 | -- | 0.46 | 0.47 | $819.9M | $801.4M |
| Feb 13, 2025 | -- | 0.75 | 0.76 | $965.6M | $979.6M |
| Nov 5, 2024 | -- | 0.61 | 0.60 | $859.4M | $864.4M |
| Aug 6, 2024 | -- | 0.52 | 0.52 | $796.5M | $800.7M |
| May 2, 2024 | -- | 0.46 | Above forecast↑0.53 | $729.9M | $721.7M |
| Feb 13, 2024 | -- | 0.65 | 0.70 | $807.5M | $854.5M |
| Nov 2, 2023 | -- | 0.63 | Above forecast↑0.74 | $715.8M | $742.8M |
| Aug 3, 2023 | -- | 0.49 | 0.50 | $647.9M | $681.9M |
| May 4, 2023 | -- | 0.55 | Above forecast↑0.64 | $639.8M | $685.3M |
| Feb 9, 2023 | -- | 0.72 | 0.74 | $680.1M | $708.4M |
Original Filings (SEC)
8-K2026-08-14 ↗
10-Q2026-08-05 ↗
8-K2026-08-04 ↗
8-K2026-07-30 ↗
8-K2026-05-21 ↗
8-K2026-05-15 ↗
10-Q2026-05-07 ↗
8-K2026-05-06 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
